Commercialization: Page 93

PharmaVoice Team/PharmaVoice

Strategy Drives Partnerships in Closed Loop Marketing

Strategy Drives Partnerships in Closed Loop Marketing Closed loop marketing (CLM) is defined as the ability to optimize customer communications by capturing initial brand interactions and measuring for marketing effectiveness and ROI, and then refining the ...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Online Marketing Is Relationship Marketing

Online Marketing Is Relationship Marketing Compass Healthcare Communications Peter H. Nalen, President and CEO Observe a typical high schooler chatting with friends through Facebook while simultaneously IM-ing classmates for homework assignments and making weekend dates via text messaging, a...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

E-Technologies: Across the Board Solutions

E-Technologies: Across the Board Solutions VIEW on E-Solutions October 2007 The pharmaceutical industry will lose patient trust within 10 years unless it learns to adapt to changes in the way healthcare will be created, delivered, and managed. This is just one of the many predictions from a ne...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Social Networks -- We're All Connected

Qi, part of CommonHealth Social Networks — We’re All Connected Marc Weiner, President Buddy Scalera, Senior Interactive Content Director A s a pharmaceutical brand manager, you’ve probably heard this a lot recently, “We need to figure out how to leverage social networks,” and justifiabl...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Connecting With Consumers Online: The Power of the Click

Connecting With Consumers Online: The Power of the Click Marketers can design online content that connects meaningfully with consumers and shapes their behavior in ways that benefit brands. Chandani Rao Director, Interactive Development Today, a sim...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Collision Course: TV and the Internet

By now, the enormity of the Internet revolution is clear, and the impact it’s having on both our personal and professional lives is becoming more evident each and every day. Specifically, in the pharmaceutical and healthcare industries, the Internet has provided a new platform from which patients...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Table of Contents

Letter from the Editor The Forum E-Technologies: Across the Board Solutions — The Internet has changed how the life-science industry conducts all aspects of its business, from marketing and sales to research and development to the supply chain — and everything in between. Company Listing by Topic...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

A-Ha Moments in Writing for the Web

A-Ha Moments in Writing for the Web JUICE Pharma Advertising Writing for the Web requires the same best practices one would follow to be engaging and effective in any medium. Yet writing for the Web requires a certain amount of planning around the environment and the audiences — and can make or...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Selecting the Right Approach to Competitive Gaming

24 S e p t e m b e r 2 0 07 VIEW on Marketing MARKET PERFORMANCE T he U.S. pharmaceutical industry operates within an extraordinar� ily competitive, complex, and high�stakes environment. With so much at risk, brand teams often choose to “pressure test” their key strategies before implementin...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Innovation in Patient Education

22 Sep t e mb e r 20 07 VIEW on Marketing E�MEDIA mazon, iTunes, and Netflix have it right. These media capture our attention, our loyalty, and our business by providing an ever�evolv� ing service platform that continues to meet our personal needs. We log on to one of these sites, and we fee...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

A Holistic View of Optimizing Brand Performance

34 S e p t e m b e r 2 0 07 VIEW on Marketing ROI s pharma companies cope with increasingly limited budgets, they are demanding that marketing be accountable for demonstrating ROI on promotional activities. For a true read on results, however, companies must move from looking at sales and ma...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Reality-Based Marketing Insights and the Power of Story

18 Sep t e mb e r 20 07 VIEW on Marketing COMMUNICATION STRATEGIES T he way we tell our personal stories can have a direct impact on our personal success, according to a recent article in the science section of The New York Times. Could the same be true in the medical realm? Could the storie...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Prelaunch Communications in a Post-Vioxx World

16 S e p t e m b e r 2 0 07 VIEW on Marketing COMMUNICATION STRATEGIES D uring any pharmaceutical marketing meeting chances are someone will utter the phrase “today’s post�Vioxx environ� ment,” meaning an environment in which the Food and Drug Administra� tion (FDA) and other regulators ar...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Letter from the Editor

Letter from the Editor VIEW on Marketing S e p t e m b e r 2 0 07 The AHF took issue with Pfizer’s most recent campaign for Viagra, pointing to recent marketing programs, such as a series of holi� day�themed print ads and, most recently, the “Viva Viagra” campaign, which the organiza� ti...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Compliance is a Journey Not an Event

32 Sep t e mb e r 20 07 VIEW on Marketing PATIENT COMPLIANCE I spent two days in Mexico City last October. With a population of more than 20 million, Greater Mexico City is immense, and flying over it takes one’s breath away. It was my first visit, and much was unfamiliar : the language, the...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

You Have Two Ears and One Mouth for a Reason

20 S e p t e m b e r 2 0 07 VIEW on Marketing COMMUNICATION STRATEGIES H ow many of us have heard “you have two ears and one mouth for a reason” from parents, teachers, or even friends trying to tell us that we are talking too much? Despite knowing this adage to be true, we all tend to want ...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Lessons from the Left Coast: What Hollywood Can Teach Pharma about Marketing

26 S e p t e m b e r 2 0 07 VIEW on Marketing MARKET PREPARATION B lockbuster�envy, high�development costs, sequels, the profitability of independent films — when marketers begin comparing pharma with Hollywood, the similarities keep coming. So what can our industry learn from Hollywood? The...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Table of Contents

S e p t e m b e r 2 0 07 VIEW on Marketing Table of Contents Letter from the Editor The Forum Marketing: The State of Marketing — The number of marketing options is increasing.To keep pace, marketing professionals must adjust to the new climate and engage with more outside providers of communicat...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Prepare Your Brand for the Market … and the Market for Your Brand

28 Sep t e mb e r 20 07 VIEW on Marketing MARKET PREPARATION C ongratulations! Your compound has successfully completed Phase II trials, you have developed an understanding of your product profile, and the drug will soon move into Phase III tri� als. The question now becomes, how do you ensu...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

The Power of Print

30 Sep t e mb e r 20 07 VIEW on Marketing MEDIA MANAGEMENT lthough many people within the pharmaceutical industry predict� ed at the beginning of the decade that healthcare professionals would want product information to be provided via electronic media, print still remains a very important and i...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

PharmaOutlet

Flawless Execution is Critical to Marketing Success Contributed by Mike Miller The brand manager gives the “green light,” the creative is done, purchase orders are signed, the piece is produced, and the date that physicians will receive the recently published pivotal study has been agreed to. Eve...
By Mike Miller • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

On the Calendar

October 15-16 Quantitative PCR, Microarrays and Biological Validation Renaissance Providence Hotel, Providence, R.I. For more information, contact Nicole Lewis, Cambridge Healthtech Institute, at 617-630-1317, e-mail [email protected], or visit healthtech.com. October 15-16 Strategic and Prac...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

PharmaTrax

Strategies to Enhance Treatment Persistence New research from Datamonitor finds that the medical establishment’s approach to adherence is changing as it becomes clear that the responsibility of achieving adherence is not solely the patient’s, but rather is shared among stakeholders. The report sh...
By PharmaVoice Team • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

The Value Equation -- Deirdre Connelly

By Kim Ribbink It’s not often that a sales representative rises to the ranks of president of a pharmaceutical company, let alone one of the giants in the industry. That Deirdre P. Connelly did so is testament to her hard work and commitment to the company — Eli Lilly and Co. — and her easy one-on...
By Kim Ribbink • Jan. 2, 2008
PharmaVoice Team/PharmaVoice

Talent Pool

Pharma POOL Dr. David E. Kelley Key Appointment in Merck’s Diabetes and Obesity Franchise Merck has named David E. Kelley, M.D., VP, franchise integrator for diabetes and obesity. Dr. Kelley oversees the lead researchers for experimental medicine, imaging, and molecular profiling. He is responsib...
By PharmaVoice Team • Jan. 2, 2008